These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 15194490

  • 1. Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition.
    Li Z, Melandri F, Berdo I, Jansen M, Hunter L, Wright S, Valbrun D, Figueiredo-Pereira ME.
    Biochem Biophys Res Commun; 2004 Jul 09; 319(4):1171-80. PubMed ID: 15194490
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of sequestosome 1/p62 up-regulation prevents aggregation of ubiquitinated proteins induced by prostaglandin J2 without reducing its neurotoxicity.
    Wang Z, Figueiredo-Pereira ME.
    Mol Cell Neurosci; 2005 Jun 09; 29(2):222-31. PubMed ID: 15911346
    [Abstract] [Full Text] [Related]

  • 3. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
    Ardley HC, Scott GB, Rose SA, Tan NG, Robinson PA.
    J Neurochem; 2004 Jul 09; 90(2):379-91. PubMed ID: 15228595
    [Abstract] [Full Text] [Related]

  • 4. Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2).
    Rockwell P, Yuan H, Magnusson R, Figueiredo-Pereira ME.
    Arch Biochem Biophys; 2000 Feb 15; 374(2):325-33. PubMed ID: 10666314
    [Abstract] [Full Text] [Related]

  • 5. An endogenous electrophile that modulates the regulatory mechanism of protein turnover: inhibitory effects of 15-deoxy-Delta 12,14-prostaglandin J2 on proteasome.
    Shibata T, Yamada T, Kondo M, Tanahashi N, Tanaka K, Nakamura H, Masutani H, Yodoi J, Uchida K.
    Biochemistry; 2003 Dec 02; 42(47):13960-8. PubMed ID: 14636064
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A role of the ubiquitin-proteasome system in neuropathic pain.
    Moss A, Blackburn-Munro G, Garry EM, Blakemore JA, Dickinson T, Rosie R, Mitchell R, Fleetwood-Walker SM.
    J Neurosci; 2002 Feb 15; 22(4):1363-72. PubMed ID: 11850463
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory properties of antitumor prostaglandins against topoisomerases.
    Suzuki K, Uyeda M.
    Biosci Biotechnol Biochem; 2002 Aug 15; 66(8):1706-12. PubMed ID: 12353631
    [Abstract] [Full Text] [Related]

  • 10. Neurodegeneration: linking ubiquitin/proteasome pathway impairment with inflammation.
    Li Z, Jansen M, Pierre SR, Figueiredo-Pereira ME.
    Int J Biochem Cell Biol; 2003 May 15; 35(5):547-52. PubMed ID: 12672447
    [Abstract] [Full Text] [Related]

  • 11. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells.
    Li Z, Arnaud L, Rockwell P, Figueiredo-Pereira ME.
    J Neurochem; 2004 Jul 15; 90(1):19-28. PubMed ID: 15198663
    [Abstract] [Full Text] [Related]

  • 12. Neurotoxic mechanisms by which the USP14 inhibitor IU1 depletes ubiquitinated proteins and Tau in rat cerebral cortical neurons: Relevance to Alzheimer's disease.
    Kiprowska MJ, Stepanova A, Todaro DR, Galkin A, Haas A, Wilson SM, Figueiredo-Pereira ME.
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun 15; 1863(6):1157-1170. PubMed ID: 28372990
    [Abstract] [Full Text] [Related]

  • 13. Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury.
    Liu H, Li W, Ahmad M, Miller TM, Rose ME, Poloyac SM, Uechi G, Balasubramani M, Hickey RW, Graham SH.
    Neurobiol Dis; 2011 Feb 15; 41(2):318-28. PubMed ID: 20933087
    [Abstract] [Full Text] [Related]

  • 14. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures.
    McNaught KS, Mytilineou C, Jnobaptiste R, Yabut J, Shashidharan P, Jennert P, Olanow CW.
    J Neurochem; 2002 Apr 15; 81(2):301-6. PubMed ID: 12064477
    [Abstract] [Full Text] [Related]

  • 15. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H, Haneda M, Sugimoto T, Inoki K, Koya D, Kikkawa R.
    Kidney Int; 2002 Jun 15; 61(6):1957-67. PubMed ID: 12028436
    [Abstract] [Full Text] [Related]

  • 16. Ubiquitin dimers control the hydrolase activity of UCH-L3.
    Setsuie R, Sakurai M, Sakaguchi Y, Wada K.
    Neurochem Int; 2009 Jun 15; 54(5-6):314-21. PubMed ID: 19154770
    [Abstract] [Full Text] [Related]

  • 17. The role of c-Myc and heat shock protein 70 in human hepatocarcinoma Hep3B cells during apoptosis induced by prostaglandin A2/Delta12-prostaglandin J2.
    Ahn SG, Jeong SY, Rhim H, Kim IK.
    Biochim Biophys Acta; 1998 Nov 19; 1448(1):115-25. PubMed ID: 9824682
    [Abstract] [Full Text] [Related]

  • 18. Cytoskeleton/endoplasmic reticulum collapse induced by prostaglandin J2 parallels centrosomal deposition of ubiquitinated protein aggregates.
    Ogburn KD, Figueiredo-Pereira ME.
    J Biol Chem; 2006 Aug 11; 281(32):23274-84. PubMed ID: 16774923
    [Abstract] [Full Text] [Related]

  • 19. [The ubiquitin-proteasome system and neurodegeneration].
    Wada K, Osaka H, Aoki S, Wang YL.
    Rinsho Shinkeigaku; 2001 Dec 11; 41(12):1072-4. PubMed ID: 12235799
    [Abstract] [Full Text] [Related]

  • 20. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
    Radón V, Czesla M, Reichelt J, Fehlert J, Hammel A, Rosendahl A, Knop JH, Wiech T, Wenzel UO, Sachs M, Reinicke AT, Stahl RAK, Meyer-Schwesinger C.
    Kidney Int; 2018 Jan 11; 93(1):110-127. PubMed ID: 28754552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.